ZA859299B - Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes,modified on its polysaccharide units - Google Patents

Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes,modified on its polysaccharide units

Info

Publication number
ZA859299B
ZA859299B ZA859299A ZA859299A ZA859299B ZA 859299 B ZA859299 B ZA 859299B ZA 859299 A ZA859299 A ZA 859299A ZA 859299 A ZA859299 A ZA 859299A ZA 859299 B ZA859299 B ZA 859299B
Authority
ZA
South Africa
Prior art keywords
prolonged
glycopeptide
constituent
modified
polysaccharide units
Prior art date
Application number
ZA859299A
Inventor
Franz Jansen
Pierre Gros
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ZA859299B publication Critical patent/ZA859299B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Prolonged-acting immunotoxin consisting of a conjugate in which an antibody or antibody fragment is coupled, via a covalent structure containing a disulphide group or a thioether group, to a ribosome-inactivating glycoprotein having a prolonged action obtained by oxidation of its saccharide moieties with periodate ions.
ZA859299A 1985-02-13 1985-12-04 Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes,modified on its polysaccharide units ZA859299B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8502068A FR2577135B1 (en) 1985-02-13 1985-02-13 LONG-TERM ACTION IMMUNOTOXINS COMPRISING A GLYCOPEPTITIDE CONSTITUENT MODIFYING RIBOSOMES MODIFIED ON ITS POLYSACCHARIDE PATTERNS

Publications (1)

Publication Number Publication Date
ZA859299B true ZA859299B (en) 1986-08-27

Family

ID=9316241

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA859299A ZA859299B (en) 1985-02-13 1985-12-04 Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes,modified on its polysaccharide units

Country Status (14)

Country Link
EP (1) EP0192002B1 (en)
JP (1) JPH0725701B2 (en)
KR (1) KR930003333B1 (en)
AT (1) ATE75487T1 (en)
AU (1) AU591077B2 (en)
CA (1) CA1264667A (en)
DE (1) DE3585951D1 (en)
DK (1) DK563585A (en)
FR (1) FR2577135B1 (en)
GR (1) GR852914B (en)
IE (1) IE59909B1 (en)
NZ (1) NZ214482A (en)
PT (1) PT81623B (en)
ZA (1) ZA859299B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566271B1 (en) * 1984-06-20 1986-11-07 Sanofi Sa NOVEL CYTOTOXIC CONJUGATES FOR USE IN THERAPEUTICS AND PROCESS FOR OBTAINING SAME
FR2573656B1 (en) * 1984-11-29 1987-02-27 Sanofi Sa MEDICINAL PRODUCT COMPRISING A COMBINATION OF AT LEAST ONE IMMUNOTOXIN AND AT LEAST ONE MANNOSE-CONTAINING POLYMER
JPH01502909A (en) * 1987-02-24 1989-10-05 ゾーマ・コーポレーション Immunosuppression in human treatment with immunotoxins
US4981979A (en) * 1987-09-10 1991-01-01 Neorx Corporation Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity
IT1249051B (en) * 1991-02-26 1995-02-11 Italfarmaco Spa IMMUNOTOXIN FROM ANTI-CD5 MONOCLONAL ANTIBODIES
US6146850A (en) 1991-11-04 2000-11-14 Xoma Corporation Proteins encoding gelonin sequences
US5376546A (en) * 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
US5621083A (en) * 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US5837491A (en) * 1991-11-04 1998-11-17 Xoma Corporation Polynucleotides encoding gelonin sequences

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL47372A (en) * 1975-05-27 1979-10-31 Yeda Res & Dev Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same
FR2437213A1 (en) * 1978-09-28 1980-04-25 Cm Ind CYTOTOXIC PRODUCTS FORMED BY COVALENT BINDING OF THE CHAIN TO RICIN WITH AN ANTIBODY AND THEIR PREPARATION METHOD
JPS5616418A (en) * 1979-07-20 1981-02-17 Teijin Ltd Antitumor protein complex and its preparation
EP0044167A3 (en) * 1980-07-14 1982-04-21 The Regents Of The University Of California Antibody targeted cytotoxic agent
FR2504010B1 (en) * 1981-04-15 1985-10-25 Sanofi Sa ANTI-CANCER MEDICINAL PRODUCTS CONTAINING THE RICIN-ASSOCIATED CHAIN ASSOCIATED WITH ANTIMELANOMA ANTIBODY AND PROCESS FOR THEIR PREPARATION
JPS5843926A (en) * 1981-09-08 1983-03-14 Suntory Ltd Selective carcinostatic agent
FR2516794B1 (en) * 1981-11-20 1985-10-25 Sanofi Sa NOVEL CANCER DRUGS FOR THE TREATMENT OF LEUKEMIA T CONTAINING RICIN AND A SPECIFIC MONOCLONAL ANTIBODY
CA1203164A (en) * 1982-03-09 1986-04-15 Thomas J. Mckearn Antibody conjugates
PT80662B (en) * 1984-06-20 1986-12-09 Sanofi Sa Process to obtain anti-tumoral glycoprotein modified on its glycidic portions

Also Published As

Publication number Publication date
ATE75487T1 (en) 1992-05-15
EP0192002A1 (en) 1986-08-27
FR2577135A1 (en) 1986-08-14
KR860006482A (en) 1986-09-11
DK563585A (en) 1986-08-14
AU5078385A (en) 1986-08-14
CA1264667A (en) 1990-01-23
AU591077B2 (en) 1989-11-30
IE853071L (en) 1986-08-13
PT81623B (en) 1988-04-21
IE59909B1 (en) 1994-04-20
FR2577135B1 (en) 1989-12-15
KR930003333B1 (en) 1993-04-26
PT81623A (en) 1986-01-01
JPH0725701B2 (en) 1995-03-22
GR852914B (en) 1986-04-07
NZ214482A (en) 1989-08-29
EP0192002B1 (en) 1992-04-29
JPS61200925A (en) 1986-09-05
DK563585D0 (en) 1985-12-05
DE3585951D1 (en) 1992-06-04

Similar Documents

Publication Publication Date Title
ZA859299B (en) Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes,modified on its polysaccharide units
ATE76752T1 (en) BLOOD SUBSTITUTE.
IE853227L (en) Modified polysaccharides and their conjugates with¹immunogenic proteins
EP0272681A3 (en) Lighting system
FI923155A (en) GELGUMMI FOER ICKE-SPROEDA GELER
GR3033553T3 (en) Site-specific conjugation of immunoglobulins and detectable labels.
ES2095847T3 (en) OXIDATIVE DENATURALIZATION OF PROTEIN ANALYTS.
AU549495B2 (en) Immunoglobulin-vindesine conjugates
IL83183A0 (en) Immunotoxins,their preparation and pharmaceutical compositions containing them
NZ235316A (en) Vaccine containing capsular polysaccharide conjugated to recombinant c protein of a group b streptococcus, production and use against b streptococcus infection
IL75484A0 (en) Antitumoral glycoproteins modified on their carbohydrate units and their preparation
EP0601318A3 (en) Process for production of a conjugate from a specific binding partner and a carbohydrate containing protein.
ES1000783U (en) Tentetieso toy (Machine-translation by Google Translate, not legally binding)
ES2003794A6 (en) Automatic door of replacement articulated sheets (Machine-translation by Google Translate, not legally binding)
ES283588U (en) Doll with articulated arms and bolts (Machine-translation by Google Translate, not legally binding)
BG51632A1 (en) Polysulphide oligomer, method for its preparation and application
ES1011226U (en) Advertising distinction and/or perfected adorno. (Machine-translation by Google Translate, not legally binding)